RxDoctor Payments Data

Samantha Gajkowski

Gerontology · Salt Lake City, UTNPI 1043912298

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations.

$2,079in general payments, 2019–2025

Across 101 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$353
  • AstraZeneca$345
  • AbbVie$309
  • Boehringer Ingelheim$208
  • Gilead$194
  • Indivior Inc.$188
  • plus $482 from 11 others

What the payments were for

  • Food & beverage$2,079100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,079 in reported general payments places this provider in the 80th percentile of 26 gerontology providers in Utah.

See all gerontology providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol72$95,776
JardianceEmpagliflozin39$39,125
TrulicityDulaglutide24$28,583
OzempicSemaglutide22$21,252
VascepaIcosapent Ethyl20$17,548
Diclofenac Sodium51$3,590
Celecoxib49$3,221
Atorvastatin Calcium191$1,919
Colchicine28$1,527
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide73$1,445
Losartan Potassium142$1,385
Omeprazole58$824
Ibuprofen43$792
Albuterol Sulfate HfaAlbuterol Sulfate25$790
Clobetasol Propionate20$720

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$345$95,77672 claims
Boehringer IngelheimJardiance$208$39,12539 claims
Lilly USA, LLCTrulicity$107$28,58324 claims
Novo NordiskOzempic$96$21,25222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 26 gerontology providers in Utah.

Other gerontology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →